Posted by Administrator on February 13th, 2006 — in Allegra Top News
Sneezing, sniffling, itchy eyes–if you have mold allergies right now you’re probably miserable.
During the summer, millions of mold spores are emited every hour from a single bale of hay. In Kansas, there’s no shortage of hay, and as a result, there’s no shortage of allergies.
But mold isn’t the only culprit right now. Weeds […]
No Comments »
Posted by Administrator on February 13th, 2006 — in Allegra Top News
JERUSALEM, Jan. 27 (UPI) — Teva said Friday it got some good news in its patent lawsuit involving a generic form of Aventis’s allergy drug Allegra.
The Israeli company said a New Jersey District Court in its patent lawsuit over Allegra denied a motion for a preliminary injunction brought by Allegra sponsors Sanofi-Aventis Pharmaceuticals and […]
No Comments »
Posted by Administrator on February 13th, 2006 — in Allegra Top News
Teva announced in a press release on Friday, January 27, 2006 a favorable court decision regarding its generic version of Allegra.
Teva Pharmaceutical Industries Ltd. (Nasdaq:TEVA) announced today that the U.S. District Court for the District of New Jersey has denied a motion filed by Aventis Pharmaceuticals, Inc. and Albany Molecular Research, Inc. for a […]
2 Comments »
Posted by Administrator on February 13th, 2006 — in Allegra Top News
French pharmaceutical company, Sanofi-Aventis, reported an increase in sales for the fourth quarter with its vaccine business continuing to impress. The company’s performance precedes two upcoming decisions later this year that will greatly impact its financial future.
Forth quarter sales rose 4.8 per cent at €7 billion, despite competition from generics for Allegra. The figure, […]
No Comments »
Posted by Administrator on February 13th, 2006 — in Allegra Top News
Abstract:
Recently, increased interest in drug transporters and research in this area has revealed that drug transporters play an important role in modulating drug absorption, distribution, and elimination. Acting alone or in concert with drug metabolizing enzymes they can affect the pharmacokinetics and pharmacodynamics of a drug. This commentary will focus on the potential role that […]
No Comments »
Posted by Administrator on February 13th, 2006 — in Allegra Top News
Abstract:
Recently, increased interest in drug transporters and research in this area has revealed that drug transporters play an important role in modulating drug absorption, distribution, and elimination. Acting alone or in concert with drug metabolizing enzymes they can affect the pharmacokinetics and pharmacodynamics of a drug. This commentary will focus on the potential role that […]
No Comments »
Posted by Administrator on February 2nd, 2006 — in Allegra Top News
Albany Molecular Research Inc. (AMRI), a provider of chemistry services to the pharmaceutical industry, has agreed to acquire ComGenex, a privately held drug discovery services company based in Budapest, Hungary.
AMRI PHOTO
D’Ambra
ComGenex was founded in 1992 and had contract revenue of about $8.5 million last year. It employs 119 people, including 88 scientific and technical staff.
According […]
No Comments »
Posted by Administrator on February 2nd, 2006 — in Allegra Top News
Albany Molecular Research Inc. (AMRI), a provider of chemistry services to the pharmaceutical industry, has agreed to acquire ComGenex, a privately held drug discovery services company based in Budapest, Hungary.
AMRI PHOTO
D’Ambra
ComGenex was founded in 1992 and had contract revenue of about $8.5 million last year. It employs 119 people, including 88 scientific and technical staff.
According […]
No Comments »
Posted by Administrator on February 2nd, 2006 — in Allegra Top News
Forth quarter sales rose 4.8 per cent at €7 billion, despite competition from generics for Allegra. The figure, which was slightly below analyst’s estimates, was also due to lower-than-expected sales for certain drugs.
The antihistamine, which since September has faced competition from generics in the US, generated net sales of €193 million, (€160 million) - down […]
No Comments »